PRESS RELEASES More events are coming soon. Keyword Search Year: 2022202120202019201820172016201520142013 02/02/22 Summary Toggle TRACON Pharmaceuticals Announces Initiation of Randomized Phase 2 Trial of TRC102 in Lung Cancer Sponsored by the National Cancer Institute Printer Friendly PDF Version 01/05/22 Summary Toggle TRACON Pharmaceuticals to Present at the H.C. Wainwright BIOCONNECT Virtual Conference Printer Friendly PDF Version 12/27/21 Summary Toggle TRACON Pharmaceuticals Announces Positive Results from the Independent Data Monitoring Committee Review of Interim Safety and Efficacy Data from the Ongoing ENVASARC Pivotal Trial Printer Friendly PDF Version 11/29/21 Summary Toggle TRACON Pharmaceuticals Reports Regulatory Approval of Envafolimab in China Printer Friendly PDF Version 11/11/21 Summary Toggle TRACON Pharmaceuticals to Present at the Jefferies London Virtual Healthcare Conference Printer Friendly PDF Version 11/03/21 Summary Toggle TRACON Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update Printer Friendly PDF Version 10/27/21 Summary Toggle TRACON to Report Third Quarter 2021 Financial Results and Company Highlights on November 3, 2021 Printer Friendly PDF Version 10/13/21 Summary Toggle TRACON Pharmaceuticals Announces Appointment of Carol Lam to its Board of Directors Printer Friendly PDF Version 10/11/21 Summary Toggle TRACON Pharmaceuticals and Eucure Biopharma, a Subsidiary of Biocytogen, Announce Partnership for Development of Clinical Stage CTLA-4 Antibody YH001 Printer Friendly PDF Version 09/13/21 Summary Toggle TRACON Pharmaceuticals to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit Printer Friendly PDF Version Pagination First page First Previous page Previous Page 1 Current page 2 Page 3 Page 4 … Next page Next Last page Last
